Start | Browse by Day | Browse by Track | Author Index | Browse Handouts

5E Measuring Program Effectiveness: Screening Coverage, Treatment, and Partner Services

Earn CE Credit for viewing the archived recordings of the 2012 STD Conference.

Deadline: April 12, 2014

For details, click Continuing Education Information

Thursday, June 12, 2014: 8:00 AM-9:10 AM
Grand Ballroom D2/E

8:00 AM
Chlamydia (CT) Screening Coverage in Female Adolescent and Young Adult Family Planning (FP) Clients: Region X Title X FP Clinics, 2009-2011
David Fine, PhD, Sarah Salomon, MPH and Wendy Nakatsukasa-Ono, MPH, Cardea Services, Seattle, WA
     
8:15 AM
Chlamydia Screening Coverage and CT Positivity (%CT+) in Family Planning/Reproductive Health (FP/RH) Clinics: Does It Matter Which Female Patients We Screen?
Sarah Salomon, MPH, Wendy Nakatsukasa-Ono, MPH and David Fine, PhD, Cardea Services, Seattle, WA
     
8:30 AM
Verifying Treatment for Reported Cases of Gonorrhea: One Aim, More Than One Approach
Virginia Bowen, PhD, MHS1, Elizabeth Torrone, PhD2 and Thomas Peterman, MD, MSc1, 1Epidemiology and Statistics Branch, Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA, 2Division of STD Prevention, CDC, Atlanta, GA
     
8:45 AM
Unpacking chlamydia screening coverage in England, including estimates of partner notification and repeat testing outcomes
Gwenda Hughes, BA (Hon), PhD, FFPH, HIV and STI Department, Center for Infectious Disease Surveillance and Control, UK, Public Health England, London, United Kingdom
     
See more of: Symposium
<< Previous Symposium | Next Symposium >>